

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
VRNA
Verona Pharma
$88.00
Strengths

Upgraded on attractively valued
Chart
$106.69 (-17.52%)
$105.16 (-16.32%)
$84.81 (+3.76%)
$37.59 (+134.10%)
VRNA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

VRNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
VRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VRNA Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayMRK
87.49
+0.36%
AZN
83.29
-0.13%
VKTX
34.42
+1.47%
TVTX
28.06
-0.32%
TEVA
18.95
-0.37%
What is VRNA current stock price?
What are VRNA stock strengths?
What risks are associated with VRNA stock?
When is VRNA next earnings report?
What is VRNA market cap and volume?
What is VRNA's current Stock IQ?
Should I buy VRNA stock right now?
Is VRNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for VRNA?
What does a 'Strong Sell' rating mean for VRNA?
What factors influence VRNA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.31%
-8.88%
+2.71%
+2.81%
+9.75%
VRNA
Verona Pharma
Current Price
$88.00
Stock Insights
Strengths

Upgraded on attractively valued
Linked to VRNA
MRK
87.49
+0.36%
AZN
83.29
-0.13%
VKTX
34.42
+1.47%
TVTX
28.06
-0.32%
TEVA
18.95
-0.37%
Chart
$106.69 (-17.52%)
$105.16 (-16.32%)
$84.81 (+3.76%)
$37.59 (+134.10%)
VRNA Analysts Opinion
VRNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
VRNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VRNA Street view is extremely bullish and have positive views on the near-term outlook
VRNA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
VRNA Latest Analysis
Merck Completes $10B Acquisition of Verona Pharma Adds COPD Drug Ohtuvayre. Merck &. Co. Inc. (NYSE:MRK) is one of the best growth stocks to buy now. On October 7 Merck &. Co. announced the completion of its acquisition of Verona Pharma (NASDAQ:VRNA). Verona Pharma is now a wholly-owned subsidiary of Merck. The acquisition is valued at ~$10 billion and was executed under the terms of an [….]
Mon Oct 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VRNA Stock trends
VRNA Stock performance
VRNA Stock analysis
VRNA investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.